FDA Drug recall D-0136-2020
10% LMD in 5% Dextrose Injection Dextran 40 in Dextrose Injection, USP, 500 mL bags, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 040…
- FDA Drug
- Class II
- terminated
- Published 2019-10-16
On 2019-10-16 the FDA classified a Class II recall of 10% LMD in 5% Dextrose Injection Dextran 40 in Dextrose Injection, USP, 500 mL bags, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 040… by Pfizer, citing lack of Assurance of Sterility: Bag has the potential to leak.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0136-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2019-10-02 |
| Published | 2019-10-16 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Pfizer |
| Distribution | US |
Product
10% LMD in 5% Dextrose Injection Dextran 40 in Dextrose Injection, USP, 500 mL bags, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7418-13
Reason
Lack of Assurance of Sterility: Bag has the potential to leak.
Identifiers
| ndc | 0409-7418-13 |
|---|---|
| ndc | 0409-7418-03 |
| ndc | 0409-7419-14 |
| ndc | 0409-7419-03 |
| code_info | Lot #: 87-095-JT Exp. 1MAR2020 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0136-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.